Cutia Therapeutics (2487.HK) Earnings Analysis
Cutia Therapeutics (2487.HK) next reports earnings on 2026-08-27. Trailing P/E -2.11.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2487.HK next report earnings?
| Next earnings date | 2026-08-27 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
2487.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-06-30 | -0.82161 HKD | n/a | n/a | n/a |
| 2025-03-23 | -0.77697 HKD | n/a | n/a | n/a |
| 2024-12-31 | -0.80006 HKD | n/a | n/a | n/a |
| 2024-08-29 | -0.70808 HKD | n/a | n/a | n/a |
2487.HK valuation and analyst view
| Trailing P/E | -2.11 |
|---|---|
| Trailing EPS | -0.99198 HKD |
| Price / book | 0.86 |
| Dividend yield | 0.00% |
| Market cap | 0.93B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Cutia Therapeutics (2487.HK)'s next earnings date?
Cutia Therapeutics is next scheduled to report on 2026-08-27.
Did 2487.HK beat earnings last quarter?
Consensus estimate data was not available for 2487.HK's 2025-06-30 report.
What is 2487.HK's current P/E ratio and EPS?
2487.HK trades at a trailing P/E of -2.11 on trailing EPS of -0.9919783426615266 HKD.
What do analysts rate 2487.HK?
2487.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.